Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1307104.RAXKP4rXQ61GRwBA8CfQ54o-j_nsCc0rqR222vUhXghxQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1307104.RAXKP4rXQ61GRwBA8CfQ54o-j_nsCc0rqR222vUhXghxQ130_assertion type Assertion NP1307104.RAXKP4rXQ61GRwBA8CfQ54o-j_nsCc0rqR222vUhXghxQ130_head.
- NP1307104.RAXKP4rXQ61GRwBA8CfQ54o-j_nsCc0rqR222vUhXghxQ130_assertion wasGeneratedBy ECO_0000203 NP1307104.RAXKP4rXQ61GRwBA8CfQ54o-j_nsCc0rqR222vUhXghxQ130_provenance.
- NP1307104.RAXKP4rXQ61GRwBA8CfQ54o-j_nsCc0rqR222vUhXghxQ130_assertion wasDerivedFrom befree-2016 NP1307104.RAXKP4rXQ61GRwBA8CfQ54o-j_nsCc0rqR222vUhXghxQ130_provenance.
- NP1307104.RAXKP4rXQ61GRwBA8CfQ54o-j_nsCc0rqR222vUhXghxQ130_assertion SIO_000772 6848204 NP1307104.RAXKP4rXQ61GRwBA8CfQ54o-j_nsCc0rqR222vUhXghxQ130_provenance.
- NP1307104.RAXKP4rXQ61GRwBA8CfQ54o-j_nsCc0rqR222vUhXghxQ130_assertion evidence source_evidence_literature NP1307104.RAXKP4rXQ61GRwBA8CfQ54o-j_nsCc0rqR222vUhXghxQ130_provenance.
- NP1307104.RAXKP4rXQ61GRwBA8CfQ54o-j_nsCc0rqR222vUhXghxQ130_assertion description "[In this study, we compared four markers [chromosome mode, marker chromosomes, and expression of the ABH blood group antigens and the Thomsen-Friedenreich antigen (using immunoperoxidase or lectin immunoperoxidase methods)] in 39 patients presenting initially with low-stage bladder carcinoma and followed 3 to 11 years or until deep muscle invasion occurred.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1307104.RAXKP4rXQ61GRwBA8CfQ54o-j_nsCc0rqR222vUhXghxQ130_provenance.